Advances in lung cancer surgery: the role of segmentectomy in early-stage management

Expert Rev Respir Med. 2024 Mar 8:1-7. doi: 10.1080/17476348.2024.2324083. Online ahead of print.ABSTRACTINTRODUCTION: The evolving landscape of surgical interventions for early-stage non-small cell lung cancer (NSCLC) necessitates a reassessment of the traditional gold standard of lobectomy versus emerging sublobar resections, prompting this critical narrative review.AREAS COVERED: This review encompasses recent randomized controlled trials, notably JCOG0802/WJOG4607L and CALGB140503, comparing lobectomy and sublobar resections for early-stage NSCLC, focusing on tumor size and recurrence rates. It also discusses the importance of individualized decision-making, future research avenues, and technological advancements in lung cancer surgery.EXPERT OPINION: In this rapidly evolving field, sublobar resections emerge as a viable alternative to lobectomy for tumors smaller than 2 cm in early-stage NSCLC, necessitating precise patient selection and ongoing technological advancements to optimize outcomes.PMID:38457174 | DOI:10.1080/17476348.2024.2324083
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research